Statera Biopharma, Inc.
STABDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001318641
Statera Biopharma, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Oct 28, 2021; 29 institutions reported holding it in 13F filings for Q4 2022, worth $197.5K in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Statera Biopharma, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 4 | 1 | −3 |
| Shares | 212.9K | 1.00K | −211.9K (−99.5%) |
| Value | $3.29K | $30 | −$3.26K (−99.1%) |
New holders (0)
Institutions that held Statera Biopharma, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
None.
Sold out (3)
Institutions that held Statera Biopharma, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Acadian Asset Management LLC | 211,836 | $3.00K |
| IFP Advisors, Inc | 87 | $271 |
| Umb Bank N A | 5 | $0 |